Total 142266 resultPre Next
Phagenyx Neuromodulationssystem erhält Zulassung in den USA By:Phagenesis, Ltd 2022-10-10
MANCHESTER, England, 10. Oktober 2022 - Phagenesis Ltd. gab heute bekannt, dass die U.S. Food and Drug Administration (FDA), die Lebensmittelüberwachungs- und Arzneimittelbehörde der Vereinigten Staaten, den Antrag auf De-Novo-Produktzulassung für...
Phagenesis Launches Phagenyx Neurostimulation System in the U.S. By:Phagenesis, Ltd 2022-10-10
MANCHESTER, England, Oct. 10, 2022 - Phagenesis Ltd, today announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx® Neurostimulation System, a first-of-its-kind therapy that uses ...
Appian appoints Antti Grönlund as Managing Director, Private Equity By:Appian Capital Advisory LLP 2022-10-10
LONDON, Oct. 10, 2022 - Appian Capital Advisory LLP ("Appian" or the "Company"), the investment advisor to long-term value-focused private equity funds that invest solely in mining and mining-related companies, today announce...
Edison Energy Acquires Alfa Energy to Help Meet Major Market Demand By:Edison Energy 2022-10-10
The integrated energy and sustainability advisory company significantly expands its geographic footprint to 22 European countries LONDON and IRVINE, Calif., Oct. 10, 2022 - Leading global energy and sustainability advisory firm Edison Ener...
Pierre Fabre toma una participación minoritaria en Gennisium Pharma By:Pierre Fabre; Gennisium 2022-10-10
- Pierre Fabre toma una participación minoritaria, a través de su filial de inversión especializada Pierre Fabre Invest, en Gennisium Pharma, una empresa innovadora especializada en medicamentos para recién nacidos prematuros y mercados...
